| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | DK0ZGA5Y2R |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | Cell membrane disrupting agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 2 | D008545 | ClinicalTrials |
| Uveal Melanoma | 2 | D000098943 | ClinicalTrials |
| Uveal Melanoma | 2 | D000098943 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4802193 |
| FDA SRS | DK0ZGA5Y2R |
CONTENTS